Breast and Cervical Cancer Screenings: A Systematic Economic Review of Patient Navigation Services

Sajal K. Chattopadhyay,Akash Pillai,Jeffrey Reynolds,Verughese Jacob,Donatus Ekwueme,Yinan Peng,Alison E. Cuellar
DOI: https://doi.org/10.1016/j.amepre.2024.06.005
IF: 6.604
2024-06-14
American Journal of Preventive Medicine
Abstract:Introduction This paper examined the economic evidence of patient navigation services to increase breast and cervical cancer screenings among historically disadvantaged racial and ethnic populations and people with lower incomes. Methods The literature search strategy for this systematic review included English-language studies conducted in high-income countries that were published from database inception to December 2022. Studies on patients with existing cancer or without healthcare system involvement were excluded. Analysis was completed in January 2023. All monetary values reported are in 2022 U.S. dollars. Results The search yielded 3 breast cancer, 2 cervical cancer, and 2 multiple cancer studies that combined breast and cervical cancer with other cancer screenings. For breast cancer screening, the intervention cost per patient ranged from 10,245. Two studies reported 740 as intervention cost per additional person screened. Changes in healthcare cost per person from 2 studies were 2,437. Two studies reported cost per quality-adjusted life year (QALY) gained of 39,159 while one study reported cost per life year (LY) gained of 103 and 56 and 924). Discussion All estimates of cost per QALY/LY saved for breast cancer screening were below a conservative threshold of $50,000 indicating that patient navigation services for breast cancer screening were cost-effective. There is limited evidence to determine cost-effectiveness of patient navigation services for cervical cancer screening.
medicine, general & internal,public, environmental & occupational health
What problem does this paper attempt to address?